CIK 0001585364 · Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- 4 Option exercise EVP & President CSCA acquired 5,733 shares (option exercise)
- 4 Option exercise CEO acquired 17,835 shares (option exercise)
- 4 Option exercise EVP & CHRO acquired 2,070 shares (option exercise)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, Gbl Ops & SC & CTO sold 7,800 shares at $27.44 ($214,032)
- 4 Grant or award EVP & CHRO acquired 12,762 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 26,738 shares (grant or award)
- 4 Grant or award CEO acquired 16,389 shares (grant or award)
- 4 Option exercise Director acquired 5,548 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 17,598 shares at $28.27 ($497,495)
- 4 Option exercise EVP & President CSCA acquired 3,611 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 8,954 shares at $27.30 ($244,444)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, Gbl Ops & SC & CTO sold 13,000 shares at $29.40 ($382,246)
- 4 Open-market sale EVP & President CHCI sold 34,983 shares at an average $27.69 ($968,560)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 6 of 41 · 805 filings